BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12406899)

  • 1. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA).
    Attanasio C; David A; Neerman-Arbez M
    Blood; 2003 Mar; 101(5):1851-6. PubMed ID: 12406899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T.
    Attanasio C; de Moerloose P; Antonarakis SE; Morris MA; Neerman-Arbez M
    Blood; 2001 Mar; 97(6):1879-81. PubMed ID: 11238133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
    Spena S; Duga S; Asselta R; Malcovati M; Peyvandi F; Tenchini ML
    Blood; 2002 Dec; 100(13):4478-84. PubMed ID: 12393540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
    Neerman-Arbez M; de Moerloose P; Honsberger A; Parlier G; Arnuti B; Biron C; Borg JY; Eber S; Meili E; Peter-Salonen K; Ripoll L; Vervel C; d'Oiron R; Staeger P; Antonarakis SE; Morris MA
    Hum Genet; 2001 Mar; 108(3):237-40. PubMed ID: 11354637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen gene mutations accounting for congenital afibrinogenemia.
    Neerman-Arbez M
    Ann N Y Acad Sci; 2001; 936():496-508. PubMed ID: 11460507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.
    Neerman-Arbez M; de Moerloose P; Bridel C; Honsberger A; Schönbörner A; Rossier C; Peerlinck K; Claeyssens S; Di Michele D; d'Oiron R; Dreyfus M; Laubriat-Bianchin M; Dieval J; Antonarakis SE; Morris MA
    Blood; 2000 Jul; 96(1):149-52. PubMed ID: 10891444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation.
    Schwarze U; Starman BJ; Byers PH
    Am J Hum Genet; 1999 Aug; 65(2):336-44. PubMed ID: 10417276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway.
    Schwarze U; Hata R; McKusick VA; Shinkai H; Hoyme HE; Pyeritz RE; Byers PH
    Am J Hum Genet; 2004 May; 74(5):917-30. PubMed ID: 15077201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family.
    Guipponi M; Masclaux F; Sloan-Béna F; Di Sanza C; Özbek N; Peyvandi F; Menegatti M; Casini A; Malbora B; Neerman-Arbez M
    Haematologica; 2022 May; 107(5):1064-1071. PubMed ID: 34196169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
    Neerman-Arbez M; de Moerloose P
    Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
    Asselta R; Duga S; Simonic T; Malcovati M; Santagostino E; Giangrande PL; Mannucci PM; Tenchini ML
    Blood; 2000 Oct; 96(7):2496-500. PubMed ID: 11001902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing.
    Margaglione M; Santacroce R; Colaizzo D; Seripa D; Vecchione G; Lupone MR; De Lucia D; Fortina P; Grandone E; Perricone C; Di Minno G
    Blood; 2000 Oct; 96(7):2501-5. PubMed ID: 11001903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
    Spena S; Asselta R; Platé M; Castaman G; Duga S; Tenchini ML
    Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational analysis of splicing errors and mutations in human transcripts.
    Kurmangaliyev YZ; Gelfand MS
    BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs.
    Asselta R; Duga S; Spena S; Santagostino E; Peyvandi F; Piseddu G; Targhetta R; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2001 Dec; 98(13):3685-92. PubMed ID: 11739173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.